CV Sciences Q2 FY26 net loss widens to USD 775,000; revenue drops 17.5% to USD 3 million vs Q2 FY25 - CVSI News | RalliesCV Sciences Q2 FY26 net loss widens to USD 775,000; revenue drops 17.5% to USD 3 million vs Q2 FY25
C
CVSI• Q2 FY26 results
- CV Sciences posted a GAAP net loss of USD 775,000 for Q2 2026, widening from a GAAP net loss of USD 261,000.
- Revenue fell 17.5% year over year to USD 3 million, down from USD 3.6 million.
- Gross margin slipped 2.3 percentage points to 48.6%.
- Operating loss widened to USD 301,000 from USD 131,000, while operating expenses declined 11.3% to USD 1.7 million.
- Adjusted EBITDA turned to a loss of USD 100,000 from positive adjusted EBITDA of USD 100,000; cash ended the quarter at USD 300,000.
•
